Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122513
Filing Date
2024-11-07
Accepted
2024-11-06 17:41:01
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20240930.htm   iXBRL 10-Q 1873476
2 EX-10.6 acad-ex10_6.htm EX-10.6 116450
3 EX-31.1 acad-ex31_1.htm EX-31.1 10861
4 EX-31.2 acad-ex31_2.htm EX-31.2 10999
5 EX-32.1 acad-ex32_1.htm EX-32.1 7735
6 EX-32.2 acad-ex32_2.htm EX-32.2 7781
7 GRAPHIC img94628292_0.jpg GRAPHIC 164469
  Complete submission text file 0000950170-24-122513.txt   7996674

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240930.xsd EX-101.SCH 941098
70 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240930_htm.xml XML 1423382
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 241432413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)